Cite
HARVARD Citation
Matin, S. et al. (2022). Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final Report. Journal of urology. 207 (4), pp. 779-788. [Online].